This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer’s disease treatment
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCholinesterase and Neurodegenerative Diseases
The PLOS One Editors retract this article [1] due to concerns about peer review integrity, authorship, and potential manipulation of the publication process. These concerns call into question the validity of the reported results. We regret that the issues were not identified prior to the article’s publication.
SG agreed with the retraction. MSM responded but expressed neither agreement nor disagreement with the editorial decision. MTI, WB, MSH, MSSR, IB, and YAM either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Musa MS, Islam MT, Billah W, Hossain MS, Rahat MSS, Bayil I, et al. Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer’s disease treatment. P Lo S One. 2024;19(12):e 0311401. doi: 10.1371/journal.pone.0311401 39689077 PMC 11651584 · doi ↗ · pubmed ↗